Schonfeld Strategic Advisors LLC Sage Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 121,316 shares of SAGE stock, worth $659,959. This represents 0.01% of its overall portfolio holdings.

Number of Shares

121,316

Previous 68,752 76.45%

Holding current value

$659,959

Previous $746,000 17.16%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.02 - $13.08 $368,999 - $687,537	52,564 Added 76.45%	121,316 $874,000
Q2 2024 Aug 14, 2024	BUY	$10.58 - $17.9 $727,396 - $1.23 Million	68,752 New	68,752 $746,000
Q4 2023 Feb 14, 2024	SELL	$17.1 - $22.26 $1.85 Million - $2.41 Million	-108,427 Reduced 83.78%	20,992 $454,000
Q3 2023 Nov 14, 2023	BUY	$16.75 - $48.98 $1.82 Million - $5.32 Million	108,596 Added 521.52%	129,419 $2.66 Million
Q2 2023 Aug 14, 2023	BUY	$40.65 - $59.54 $846,454 - $1.24 Million	20,823 New	20,823 $979,000
Q4 2022 Feb 14, 2023	BUY	$32.2 - $43.61 $182,509 - $247,181	5,668 Added 61.58%	14,872 $567,000
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $297,105 - $398,257	9,204 New	9,204 $360,000
Q2 2022 Aug 15, 2022	SELL	$27.52 - $37.99 $459,033 - $633,673	-16,680 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$30.71 - $45.71 $512,242 - $762,442	16,680 New	16,680 $552,000
Q2 2021 Aug 16, 2021	SELL	$54.88 - $79.29 $841,475 - $1.22 Million	-15,333 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$70.65 - $96.76 $1.08 Million - $1.48 Million	15,333 New	15,333 $1.15 Million
Q3 2020 Nov 16, 2020	SELL	$41.13 - $62.45 $824,656 - $1.25 Million	-20,050 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$25.95 - $43.15 $321,286 - $534,240	12,381 Added 161.44%	20,050 $834,000
Q1 2020 May 15, 2020	BUY	$26.15 - $77.24 $107,502 - $317,533	4,111 Added 115.54%	7,669 $220,000
Q4 2019 Feb 14, 2020	SELL	$60.18 - $154.77 $772,831 - $1.99 Million	-12,842 Reduced 78.3%	3,558 $257,000
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $2.3 Million - $3.12 Million	16,400 New	16,400 $2.3 Million
Q4 2018 Feb 14, 2019	SELL	$81.94 - $139.71 $729,266 - $1.24 Million	-8,900 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$138.11 - $169.04 $1.23 Million - $1.5 Million	8,900 New	8,900 $1.26 Million

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Sage Therapeutics, Inc. Transaction History